aldo-keto reductase 1C3 inhibitor (Bayer)

N/A

Report date: 2025/03/17 20:00:36

NME

Base Information

Drug Namealdo-keto reductase 1C3 inhibitor (Bayer)

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionAldo-keto-reductase family 1 member C3 inhibitors

TargetsAldo-keto-reductase family 1 member C3

Therapy Area/IndicationsEndometriosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesBayer AG

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesBayer AG

Active IndicationsN/A

Inactive IndicationsEndometriosis

ATC CodeN/A